Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cue Biopharma Inc V.CUE


Primary Symbol: CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.


NDAQ:CUE - Post by User

Post by Hercules007on Oct 20, 2011 8:36pm
537 Views
Post# 19168728

results just out!

results just out!Hi! I am new to this board but I thoufght you might find this interesting! It came out after market! They are most certainly terrific numbers! Just thought I would let you guys know!

Happy Creek drills 12.4 metres of 0.74% W03 (tungsten trioxide) on the Fox property, B.C.
10/20/2011 2:00 PM - NW

Happy Creek drills 12.4 metres of 0.74% W03 (tungsten trioxide) on the Fox property, B.C.

(via Thenewswire.ca)

October 20, 2011 - Vancouver, British Columbia - Happy Creek Minerals Ltd. (TSX-V: HPY, the "Company") is very pleased to announce additional results from the first ever diamond drill program on the Ridley Creek area of its 100% owned Fox tungsten property. The Fox property is located approximately 30 kilometres east of the past producing Boss Mountain molybdenum mine and 75 kilometres northeast of 100 Mile House, in south central British Columbia, Canada. Due largely to limitation of exports from China, tungsten has maintained a price over $400 per Metric Tonne Unit or $40.0 per kg* (kilogram) of W03 (tungsten trioxide).

Ridley Creek Area Drill Results

---------------------------------------------------------|        |From  |To    |Interval|W03 |W03     |Zn  |In  ||-------------------------------------------------------||Hole #  |metres|metres|metres  |%   |kg/tonne|%   |g/t ||-------------------------------------------------------||F11-07  |14.30 |19.00 |4.70    |1.02|10.2    |0.42|2.3 ||-------------------------------------------------------||includes|14.85 |15.25 |0.40    |9.60|96.0    |3.64|19.2||-------------------------------------------------------||F11-08  |8.25  |20.65 |12.40   |0.74|7.4     |0.15|0.9 ||-------------------------------------------------------||includes|18.75 |19.40 |0.65    |8.15|81.5    |1.87|10.9|---------------------------------------------------------
<< Previous
Bullboard Posts
Next >>